The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Adaptations for the Oxidation of Polycyclic Aromatic Hydrocarbons Exhibited by the Structure of Human P450 1A2
Open accessAbstract
Microsomal cytochrome P450 family 1 enzymes play prominent roles in xenobiotic detoxication and procarcinogen activation. P450 1A2 is the principal cytochrome P450 family 1 enzyme expressed in human liver and participates extensively in drug oxidations. This enzyme is also of great importance in the bioactivation of mutagens, including the N-hydroxylation of arylamines. P450-catalyzed reactions involve a wide range of substrates, and this versatility is reflected in a structural diversity evident in the active sites of available P450 structures. Here, we present the structure of human P450 1A2 in complex with the inhibitor alpha-naphthoflavone, determined to a resolution of 1.95 A. alpha-Naphthoflavone is bound in the active site above the distal surface of the heme prosthetic group. The structure reveals a compact, closed active site cavity that is highly adapted for the positioning and oxidation of relatively large, planar substrates. This unique topology is clearly distinct from known active site architectures of P450 family 2 and 3 enzymes and demonstrates how P450 family 1 enzymes have evolved to catalyze efficiently polycyclic aromatic hydrocarbon oxidation. This report provides the first structure of a microsomal P450 from family 1 and offers a template to study further structure-function relationships of alternative substrates and other cytochrome P450 family 1 members.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
Likelihood-enhanced fast translation functions
McCoy, A. J., Grosse-Kunstleve, R. W., Storoni, L. C., & Read, R. J. (2005) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444905001617 · Cited by 1,639
Gotoh, O. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48462-1 · Cited by 1,194
Nebert, D. W., Dalton, T. P., Okey, A. B., & Gonzalez, F. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400004200 · Cited by 1,182
Detection, delineation, measurement and display of cavities in macromolecular structures
Kleywegt, G. J., & Jones, T. A. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444993011333 · Cited by 969
Crystal structure of human cytochrome P450 2C9 with bound warfarin
Williams, P. A., Cosme, J., Ward, A., Angove, H. C., Matak Vinković, D., & Jhoti, H. (2003) · Nature · doi:10.1038/nature01862 · Cited by 821
Crystal Structures of Human Cytochrome P450 3A4 Bound to Metyrapone and Progesterone
Williams, P. A., Cosme, J., Vinković, D. M., Ward, A., Angove, H. C., Day, P. J., Vonrhein, C., Tickle, I. J., & Jhoti, H. (2004) · Science · doi:10.1126/science.1099736 · Cited by 806
Yano, J. K., Wester, M. R., Schoch, G. A., Griffin, K. J., Stout, C. D., & Johnson, E. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400293200 · Cited by 705
Self-citationMammalian Microsomal Cytochrome P450 Monooxygenase
Williams, P. A., Cosme, J., Sridhar, V., Johnson, E. F., & McRee, D. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80408-6 · Cited by 696
Self-citationFlavonoids-potent and versatile biologically active compounds interacting with cytochromes P450
Hodek, P., Trefil, P., & Stiborová, M. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(01)00285-x · Cited by 649
[10] Electron-density map interpretation
Jones, T. A., & Kjeldgaard, M. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)77012-5 · Cited by 505
The Structure of Human Cytochrome P450 2C9 Complexed with Flurbiprofen at 2.0-Å Resolution
Wester, M. R., Yano, J. K., Schoch, G. A., Yang, C., Griffin, K. J., Stout, C. D., & Johnson, E. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405427200 · Cited by 440
Self-citationCrystal Structure of Human Cytochrome P450 2D6
Rowland, P., Blaney, F. E., Smyth, M. G., Jones, J. J., Leydon, V. R., Oxbrow, A. K., Lewis, C. J., Tennant, M. G., Modi, S., Eggleston, D. S., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511232200 · Cited by 437
Structure of Human Microsomal Cytochrome P450 2C8
Schoch, G. A., Yano, J. K., Wester, M. R., Griffin, K. J., Stout, C. D., & Johnson, E. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312516200 · Cited by 382
Self-citationde Visser, S. P., & Shaik, S. S. (2003) · Journal of the American Chemical Society · doi:10.1021/ja034142f · Cited by 368
An open conformation of mammalian cytochrome P450 2B4 at 1.6-Å resolution
Scott, E. E., He, Y. A., Wester, M. R., White, M. A., Chin, C. C., Halpert, J. R., Johnson, E. F., & Stout, C. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133986100 · Cited by 339
Self-citationCytochrome P450 Gene Polymorphism and Cancer
Agundez, J. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335621 · Cited by 292
Scott, E. E., White, M. A., He, Y. A., Johnson, E. F., Stout, C. D., & Halpert, J. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403349200 · Cited by 279
Self-citationCYTOCHROME P450 ACTIVATION OF ARYLAMINES AND HETEROCYCLIC AMINES
Kim, D., & Guengerich, F. P. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.100010 · Cited by 250
Selectivity of Polycyclic Inhibitors for Human Cytochrome P450s 1A1, 1A2, and 1B1
Shimada, T., Yamazaki, H., Foroozesh, M., Hopkins, N. E., Alworth, W. L., & Guengerich, F. P. (1998) · Chemical Research in Toxicology · doi:10.1021/tx980090+ · Cited by 223
Oxidation of Benzo[a]pyrene by Recombinant Human Cytochrome P450 Enzymes
Bauer, E., Guo, Z., Ueng, Y.-F., Bell, L. C., Zeldin, D., & Guengerich, F. P. (1995) · Chemical Research in Toxicology · doi:10.1021/tx00043a018 · Cited by 212
A role for Asp-251 in cytochrome P-450cam oxygen activation.
Gerber, N. C., & Sligar, S. G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41772-8 · Cited by 195
Sandhu, P., Guo, Z. Y., Baba, T., Martin, M. V., Tukey, R. H., & Guengerich, F. P. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1099 · Cited by 184
Wester, M. R., Johnson, E. F., Marques-Soares, C., Dijols, S., Dansette, P. M., Mansuy, D., & Stout, C. D. (2003) · Biochemistry · doi:10.1021/bi034556l · Cited by 168
Self-citationRate-Determining Steps in Phenacetin Oxidations by Human Cytochrome P450 1A2 and Selected Mutants
Yun, C., Miller, G. P., & Guengerich, F. P. (2000) · Biochemistry · doi:10.1021/bi000869u · Cited by 121
Parikh, A., Josephy, P. D., & Guengerich, F. P. (1999) · Biochemistry · doi:10.1021/bi990142+ · Cited by 99
Lewis, D. F. V., & Lake, B. G. (1996) · Xenobiotica · doi:10.3109/00498259609046745 · Cited by 85
Quattrochi, L. C., Pendurthi, U. R., Okino, S. T., Potenza, C., & Tukey, R. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.6731 · Cited by 66
Structures of Cytochrome P450 Enzymes
Poulos, T. L., & Johnson, E. F. (2007) · Springer eBooks · doi:10.1007/0-387-27447-2_3 · Cited by 58
Self-citationTight-binding inhibition by α-naphthoflavone of human cytochrome P450 1A2
Cho, U., Park, E. Y., Dong, M. S., Park, B. S., Kim, K., & Kim, K. H. (2003) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/s1570-9639(03)00148-1 · Cited by 42
Purification and crystallization of N-terminally truncated forms of microsomal cytochrome P450 2C5
Wester, M. R., Stout, C. D., & Johnson, E. F. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)57667-9 · Cited by 32
Self-citation
Cited by
Zanger, U. M., & Schwab, M. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.007 · Cited by 4,169
“The crystal structure of CYP1A2 in complex with αnaphthoflavone revealed a rather compact active site with a cavity volume of 375 Ǻ3, which is larger than that of CYP2A6 (260 Ǻ3) but much smaller compared to CYPs 3A4 and 2C8 (~1400 Ǻ3; Sansen et al., 2007).”
BackgroundCytochrome P450 and Chemical Toxicology
Guengerich, F. P. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700079z · Cited by 1,725
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
Gleeson, M. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701122q · Cited by 969
Recent progresses in small-molecule enzymatic fluorescent probes for cancer imaging
Liu, H.-W., Chen, L., Xu, C., Li, Z., Zhang, H., Zhang, X.-B., & Tan, W. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00862g · Cited by 948
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Metadata
- Authors
- Sansen, S., Yano, J. K., Reynald, R. L., Schoch, G. A., Griffin, K. J., Stout, C. D., & Johnson, E. F.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 282
- Issue
- 19
- Pages
- 14348-14355
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2021232512
- Cited by
- 478
- References
- 33
- FWCI
- 23.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.